ETF Copilot
Health & Biotech

Is XLV a good investment?

Updated October 28, 2026

State Street Health Care Select Sector SPDR ETF (XLV) is a healthcare and biotech ETF. As of October 28, 2026, ETF Copilot scores XLV 5.4 out of 10 — highest on Risk (8.3), lowest on Value (0.7). It trades at 33.4 times earnings, against its own median of 25.1. Its ten largest holdings are 61% of the fund.

What stands out in XLV's data

U.S. healthcare sector, weighted by market value.

Carries a richer price tag than most healthcare peers — you pay more for each dollar of earnings.

Trailing P/E multiple of 33.4x sits above the category median of 29.6x and well above its own five-year median of 25.0x. Its 0.08% expense ratio is a fraction of the 0.47% category norm.

A core healthcare allocation, priced for the stability the sector is known for.

How is XLV rated? ETF Copilot scores State Street Health Care Select Sector SPDR ETF (XLV) 5.4 out of 10

As of October 28, 2026, ETF Copilot scores State Street Health Care Select Sector SPDR ETF (XLV) 5.4 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

  • Overall: 5.4 / 10
  • Growth: 5.8 / 10
  • Value: 0.7 / 10
  • Risk: 8.3 / 10
  • Quality: 6.9 / 10
  • Return: 5.3 / 10

Is XLV expensive right now? It trades at 33.4 times earnings, against its own median of 25.1

As of October 28, 2026, XLV is more expensive than 98% of its own last 9 years.

Trailing 12 months, built from XLV's holdings. How we calculate this →

What's inside XLV?

What's inside XLV: Size (Large 96%, Mid 5%, Small 0%); Geography (International 2%, US 98%); AI 0.3%.

What are XLV's top holdings? The ten largest are 61% of the fund

Eli Lilly, Johnson + Johnson, Abbvie, UnitedHealth, Merck, Thermo Fisher Scientific, Amgen, Gilead Sciences, Abbott Laboratories and Pfizer are XLV's largest holdings, in that order.

More concentrated than 81% of Health & Biotech ETFs.

Half of XLV's weight sits in its 7 largest positions, and once those weights are taken into account it behaves like 17 equally weighted holdings.

What is XLV's expense ratio? 0.08% a year

As of October 28, 2026, XLV charges 0.08% a year, yields 1.42% and holds $47.0B in assets across 61 positions.

State Street Health Care Select Sector SPDR ETF (XLV) — cost, income and size
MeasureXLV
Expense ratio0.08%
Dividend yield1.42%
Assets under management$47.0B
Holdings61

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Cite this

ETF Copilot, “State Street Health Care Select Sector SPDR ETF (XLV) scores and holdings analysis”, as of October 28, 2026.
https://etf-copilot.com/etf/xlv

ETF Copilot Pro unlocks XLV's price and what each holding weighs.

Try Pro free →